Gene Mutations in Male Breast Cancer

Prevalence of Gene Mutations

• Male breast cancer is strongly associated with BRCA2 mutations, with BRCA2 carriers having a 6-7% lifetime risk of developing breast cancer compared to the general population 1

Genetic Testing Criteria

• Male breast cancer alone is considered a criterion for genetic testing, regardless of family history 2
• Widely accepted clinical criteria for BRCA testing include male breast cancer with early onset female breast cancer in the family 4

Other Genetic Considerations

• TP53 mutations (associated with Li-Fraumeni syndrome) account for <1% of breast cancer families 1
• CHEK2 mutations confer a moderate risk of breast cancer and may contribute to some male cases 6
• PALB2 mutations have been described in some male breast cancer cases 6

Clinical Implications

• Identification of BRCA2 mutations in male breast cancer patients has important implications, including an increased risk of other cancers, such as prostate (5-25%), pancreatic (up to 2%), and stomach cancers 5
• Family members should be offered genetic counseling and testing 7
• Cascade testing of relatives can identify at-risk individuals who may benefit from enhanced surveillance or risk-reducing interventions 7